A 21st Century Approach to Managing and Monitoring IBD - Nurses
Jointly provided by Postgraduate Institute for Medicine and RMEI, LLC.
Supported by independent educational grants from AbbVie, Inc., Prometheus Laboratories, Inc., and Salix Pharmaceuticals Inc.
Scroll to the Bottom of this Information to Begin This Course
Release date: 10/1/2014
Valid through: 10/1/2015
Estimated Time to Complete Activity: 45 minutes
This activity has been designed to meet the educational needs of physicians, registered nurses, nurse practitioners and physician assistants who are involved in the care of patients with inflammatory bowel disease.
Upon completion of this activity, participants should be better able to:
- Describe efficacy and safety data for existing, new, and emerging treatments for inflammatory bowel diseases (IBD)
- Select individualized IBD treatments that maximize the opportunity to achieve remission, avoid relapse, and minimize complications
- Employ ongoing monitoring strategies assessing treatment goals and implement changes in treatment plans as appropriate
- Provide appropriate care and counsel for patients and their families
- Nurses — 0.75 Contact Hour / 0.50 Contact Hour of Pharmocotherapy credit for APRNs
Physicians and other health care professionals should take A 21st Century Approach to Managing and Monitoring IBD - Physician to recieve a maximum of 0.75 AMA PRA Category 1 Credit(s)™.
All other health care professionals completing this course will be issued a statement of participation.
Miguel D. Regueiro, MD
Professor of Medicine
Associate Chief for Education
Co-Director, Inflammatory Bowel Disease Center
Head, IBD Clinical Program
University of Pittsburgh
Nursing Continuing Education
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 0.75 contact hour is provided by Postgraduate Institute for Medicine. Designated for 0.50 contact hour of pharmocotherapy credit for APRNs.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
- Consulting Fees: AbbVie, Janssen, Shire, Takeda, UCB
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following RMEI, LLC planners and managers, Jacqui Brooks, MBBCh, MRCPsych, Boris Rozenfeld, MD, and Nora Hartley hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the post-test and the evaluation form. If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.